Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,416 total articles
LiqTech International, a clean technology firm specializing in advanced filtration systems, will release its second quarter 2026 financial results on August 12, 2026, before market open. A conference call and webcast will follow to discuss the results.
Super League, a Nasdaq-listed company specializing in audience intelligence and media activation for the global gaming population, will release its Q2 2026 financial results on August 14, 2026, accompanied by a live webinar to discuss the results.
KULR Technology Group, a NYSE American-listed company specializing in high-power energy systems for AI and mission-critical applications, announced its Q2 2026 earnings call on August 13, 2026. The company will release its financial results prior to the call and provide details for investors to participate.
CytomX Therapeutics announced its Q2 2026 financial results and provided updates on its clinical pipeline, focusing on Varsetatug masetecan (Varseta-M) for colorectal cancer with Phase 1 data expected by the end of 2026 and planned registrational studies in 2027. Expansion into other GI cancers and combination studies are underway. The company also…
Valhi, Inc. reported net income of $22.3 million ($0.78 per share) in Q2 2026, a significant increase from $0.9 million ($0.03 per share) in Q2 2025. The company's Chemicals segment showed strong sales and operating income growth due to market share gains, cost reductions, and strategic price increases. The Component Products segment also experienc…
ESCO Technologies Inc. announced a strong third quarter fiscal 2026 performance, highlighting a 14% increase in sales to $339 million, a 38% increase in adjusted EPS to $2.20, and record backlog of $1.54 billion. The company raised its full-year sales guidance to $1.30-$1.33 billion and adjusted EPS guidance to $8.30-$8.40, signaling robust growth …
Cognition Therapeutics reported Q2 2026 financial results highlighting progress in their Phase 3 clinical trial planning for zervimesine (CT1812), a treatment for dementia with Lewy bodies (DLB) psychosis. They received FDA feedback clarifying trial design, secured a patent allowance extending intellectual property protection through 2045, and exte…
Alta Equipment Group Inc. reported its second quarter 2026 financial results, showing sequential revenue growth across all segments despite a slight year-over-year revenue decline. The company improved new and used equipment sales gross margins, service gross profit percentages, and reduced interest expenses. Adjusted EBITDA remained stable year-ov…
Valhi, Inc., operating in chemicals, component products, and real estate management, declared a regular quarterly dividend of $0.08 per share payable on September 24, 2026.
Starling Oncology, a value-based community oncology group listed on NASDAQ as STLN, announced solid financial results for Q2 2026 with a 34.6% revenue increase year-over-year to $161.3 million and adjusted EBITDA turning positive at $229 thousand. The company raised its full-year 2026 guidance for revenue to $650-$670 million and gross profit to $1…
Applied Optoelectronics, Inc. reported a strong second quarter 2026 with record revenue of $191.9 million, marking the fifth consecutive quarter of growth. The company returned to non-GAAP profitability with net income of $5.5 million and saw a doubling in volume for its 800G products. The outlook remains positive with expected revenue growth and e…
Nephros, Inc., a Nasdaq-listed water filtration technology company, announced record financial results for Q2 ended June 30, 2026. The company achieved a 36% increase in net revenue year-over-year to $6 million, driven by 27% growth in core programmatic revenue and substantial expansion in service offerings. Net income rose significantly to $1.2 mi…
iRhythm Holdings, Inc. announced the acquisition of VitalConnect, a wearable biosensor and ambulatory cardiac monitoring company, for approximately $287.5 million. The acquisition expands iRhythm's cardiac monitoring portfolio to include mobile cardiac telemetry and multi-vitals monitoring across ambulatory, inpatient, and hospital-to-home care set…
AMD announced the acquisition of Taalas, a Canadian AI inference silicon pioneer, aiming to bolster its AI roadmap with advanced inference performance and efficiency. The integration of Taalas' technology will complement AMD's existing AI hardware and software portfolio, enhancing system-level solutions for AI inference workloads across multiple ap…
CVRx, Inc. announced a 16% increase in total revenue for Q2 2026 compared to the prior year, driven primarily by U.S. sales growth and expanded active implanting centers. Despite revenue gains and improved reimbursement policies—including new Medicare Advantage coverage from Humana—the company updated its full-year outlook lower due to fewer sales …
Apyx Medical Corporation reported strong second quarter 2026 financial results with total revenue of $13.9 million, a 22% increase year-over-year, primarily driven by 28% growth in its Surgical Aesthetics segment. The company successfully launched the power liposuction handpiece for its AYON Body Contouring System and reaffirmed full-year revenue g…
Trevi Therapeutics reported Q2 2026 financial results and significant progress with its investigational therapy Haduvio (oral nalbuphine ER) targeting chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (ILD), and refractory chronic cough (RCC). The company initiated its first Phase 3 trial and a Ph…
Surrozen, Inc. announced its Q2 2026 financial results and business progress, including a planned IND submission for its SZN-8141 drug candidate targeting diabetic macular edema (DME) by end of Q3 2026 and beginning its Phase 1b/2a clinical study, DUET, by year-end 2026. The company also reported a key US patent challenge was denied, strengthening …
Arteris, Inc. announced strong financial results for Q2 2026, highlighted by record revenue, annual contract value plus royalties growing 44% year-over-year to $99.5 million, and robust design start activity increasing 21% year-over-year. The company updated its guidance for Q3 and full year 2026, reflecting confidence in its growth driven by AI-en…
Tyson Foods, Inc. announced a quarterly dividend of $0.51 per Class A share and $0.459 per Class B share, payable December 15, 2026. This dividend reaffirmation reflects Tyson's solid financial position and commitment to returning value to shareholders.
iRhythm Holdings announced its Q2 2026 financial results, highlighting a 20.1% revenue increase to $224.2 million, improved gross margins to 72.8%, and near breakeven GAAP net loss with a significant improvement compared to the prior year. The company raised its full-year 2026 revenue and adjusted EBITDA margin guidance, entered a definitive agreem…
Nano Dimension Ltd. reported Q2 2026 revenue of $29 million, a 12.1% year-over-year increase driven by the Essemtec product line. Gross margin improved significantly to 45.9% from 27.3% last year. The company is executing strategic actions including the sale of MarkForged, Inc. to Stratasys and the sale of AME and Fabrica product lines, expected to…
Oculis Holding AG announced its Q2 2026 financial results and significant progress in its pivot to neuro-ophthalmology. The company is advancing its lead late-stage asset, Privosegtor, in the PIONEER registrational program for optic neuritis and acute multiple sclerosis relapses following positive FDA pre-IND feedback. Enrollment in the Licaminlima…
Toll Brothers, a leading luxury home builder, is selling nine professionally decorated, fully furnished model homes at Regency at Folsom Ranch, an active-adult community in Folsom, California. These homes, from the popular Sequoia, Redwood, and Tahoe collections, range from approximately 1,400 to 2,400 square feet and offer upscale features and res…
Toll Brothers, a leading US luxury homebuilder, has opened its newest luxury condominium community, Rivington Landing, in Danbury, Connecticut. The development features thoughtfully designed single-level residences with high-end finishes, access to premium amenities, and convenient location near major commuter routes. Pricing for condos starts in t…
